###begin article-title 0
Endothelial Nitric Oxide Gene T-786C Polymorphism and Subarachnoid Hemorrhage in Korean Population
###end article-title 0
###begin p 1
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 939 943 939 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1087 1088 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1116 1120 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1276 1280 1273 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
We aimed to elucidate whether the eNOS T-786C mutant allele is implicated in subarachnoid hemorrhage (SAH) susceptibility or vasospasm after SAH, and whether the mutant allele is differentially expressed in those with small and large ruptured aneurysms in Korean population. 136 consecutive patients diagnosed with aneurismal SAH and 113 controls were recruited. Polymerase chain reaction and direct sequencing of both strands were performed to determine genotypes with respect to the eNOS T-786C mutation. No significant difference was found between cases and controls with respect to the distributions of the two eNOS T-786C single nucleotide polymorphism (SNP) genotypes. No significant differences in the distributions of the eNOS T-786C SNP genotypes were found with regard to the sizes of ruptured aneurysms or the occurrence of vasospasm after SAH. Multiple logistic regression analysis after controlling for age and sex showed the eNOS T-786C SNP T/C genotype was independently associated with an unfavorable outcome (GOS grade 3-5) of SAH (Exp (beta)=4.27, 95% CI 1.131-16.108, p=0.032). In conclusion, the eNOS T-786C mutation was not found to be associated with either a susceptibility to SAH or vasospasm after SAH, or with aneurysm size in Korean population. The eNOS T-786C SNP T/C genotype could be used as a prognostic marker in individuals with SAH.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 105 112 <span type="species:ncbi:9606">persons</span>
Subarachnoid hemorrhage (SAH) produced by a ruptured intracranial aneurysm (IA) affects about 10/100,000 persons annually (1). And, although significant advances have been made in the treatment of aneurismal SAH and vasospasm (2), SAH is currently a significant healthcare problem; moreover, delayed ischemic neurological deterioration (DIND) due to vasospasm remains the greatest cause of morbidity and mortality after SAH (3). The catastrophic consequences of a ruptured IA and the high frequency of IA in the general population demand intensive efforts to define a multifactorial risk model for the identification of those at risk of developing an IA, of rupture of an existing IA, and those at risk of DIND after SAH.
###end p 3
###begin p 4
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
It is known that smoking, alcohol consumption, and hypertension are common risk factors of aneurismal SAH (4). In addition, to these environmental risk factors, genetic factors also play an important role in the pathogenesis of SAH and IAs, as the first degree relatives of patients with the disorder have up to a seven times greater risk than the general population (5), and about 10% of patients with an aneurismal SAH have first or second degree relatives with SAH or unruptured IAs (6). As this familial predisposition is the strongest risk factor for the development of IA (4), the detection of genetic risk factors could provide further diagnostic capabilities.
###end p 4
###begin p 5
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
Disruption of the extracellular matrix is likely to be a factor in the pathophysiology of IA, because IAs are associated with heritable connective tissue and extracellular matrix disorders (7). In this context, the genes involved in maintaining the integrity of the extracellular matrix have been proposed to be the most likely candidates for predisposing an individual to IA development. However, variations in these genes only explain a small proportion of the genetic factors involved in IA (8). Therefore, further studies are needed to identify candidate genes and to help unravel the pathophysiology of this disorder.
###end p 5
###begin p 6
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 363 369 <span type="species:ncbi:9606">humans</span>
Given mounting evidence that genetic factors play a role in IA formation and rupture (1, 9-11), the endothelial nitric oxide synthase gene (eNOS) is being considered as a potential candidate gene that contributes to IA formation and vasospasm after SAH, based on its normal physiologic effects on the cerebral arteries. In the arterial endothelium of animals and humans, the synthesis of nitric oxide (NO) from L-arginine is catalyzed by the enzyme eNOS (12), and the continuously generated NO serves to maintain basal vascular tone and cerebral blood flow (CBF) (13-15). In addition, when one considers that the preferential location of IAs is at the bifurcation of the conductive cerebral arteries in the subarachnoid space (16), it can be hypothesized that hemodynamic change in CBF induced by defective eNOS metabolism may affect the cerebral arterial walls lacking or with disrupted internal elastic lamina, and that this facilitates aneurysm formation (16, 17).
###end p 6
###begin p 7
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
In the present study, the authors aimed to elucidate both whether the eNOS T-786C mutant allele is implicated in susceptibility to SAH, and DIND after SAH, and additionally, to determine whether this mutant allele is differentially expressed in those with a small or large ruptured aneurysm.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Subjects
###end title 9
###begin p 10
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1220 1222 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1307 1309 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1408 1410 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 411 418 <span type="species:ncbi:9606">patient</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
###xml 795 807 <span type="species:ncbi:9606">participants</span>
###xml 896 904 <span type="species:ncbi:9606">patients</span>
###xml 1328 1336 <span type="species:ncbi:9606">patients</span>
A total of 249 human subjects were enrolled in this prospective case-control study. Of 136 consecutive patients (cases) diagnosed with aneurismal SAH based on clinical and radiological findings (including cerebral angiography in all cases), 3 were excluded from analysis because of a previous history of cerebral infarction or myocardial ischemia. During same period, 113 controls were recruited from among out-patient clinic patients with various clinical diagnoses. The control inclusion criteria were as follows; no cerebral vascular abnormality, including aneurysm or thrombosis on CT or MR angiography, no history of a vascular headache or myocardial ischemia, and no definite brain lesion on MR imaging. Demographic and medical history and peripheral blood specimen were obtained from all participants. The maximal diameters of ruptured aneurysms were measured by neuroradiologists and the patients were divided by size into 3 groups in-line with the findings of aneurysm natural history studies (18, 19), i.e., small (</=5 mm), medium (6 to 9 mm), and large (>/=10 mm). SAH severity on admission was classified based on CT scan findings according to the grading system described by Fisher (Fisher grades 1 to 4) (20). Clinical SAH severity on admission was scored using the Glasgow Coma Scale (GCS) (21). The outcomes of patients with SAH were classified according to the Glasgow Outcome Scale (GOS) (22); favorable outcome group (GOS 1), good recovery; GOS 2, moderate disability; and an unfavorable outcome group GOS 3, severe disability; GOS 4, persistent vegetative state; GOS 5, death. The study protocol was approved by our institutional review board and all subjects enrolled in the study gave informed consent.
###end p 10
###begin title 11
Genetic analysis
###end title 11
###begin p 12
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 447 448 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA was extracted from peripheral blood lymphocytes using a standard protocol. Polymerase chain reaction (PCR) primers for eNOS T-7896C SNP were designed based on GenBank sequences (accession number: NM_000603); 5'-GCA TGC ACT CTG GCC TGA AGT-3'(forward) and 5'-CAG GAA GCT GCC TTC CAG TGC-3'(reverse). PCR assays were carried out using 1.25 U of AmpliTaq polymerase Gold (Applied Biosystem, NJ, U.S.A.), 100 ng genomic DNA, 2.0 mM of MgCl2, and 10 microM of primer. Amplification conditions were as follows: an initial denaturing cycle at 95℃ for 7 min, followed by 35 amplification cycles (denaturation at 94℃ for 30 sec, annealing at 61℃ for 45 sec, and extension at 72℃ for 1 min), and a final extension step of 72℃ for 5 min. PCR products were electrophoresed in a 1.2% agarose gel, and the amplified genomic DNA fragments were extracted from the gel and purified using a QIAquick(R) gel extraction kit (Quiagen, Hilden, Germany) according to the manufacturer's instructions. Direct sequencing of both strands was performed using BigDye terminator kits (PE Biosystems, CA, U.S.A.) to determine individual genotypes.
###end p 12
###begin title 13
Data analysis
###end title 13
###begin p 14
###xml 47 59 <span type="species:ncbi:9606">participants</span>
When the clinical characteristics of the study participants were considered, hypertension was defined as blood pressures >140/95 mmHg, and diabetes mellitus as a fasting blood glucose level of >126 mg/dL or a random blood glucose concentration of >200 mg/dL.
###end p 14
###begin p 15
###xml 110 111 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 467 468 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 636 637 630 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Continuous variables were compared using 2-tailed unpaired t-tests. Categorical variables were compared by chi2 analysis with Fisher's exact test. Multiple logistic regression analysis with forward stepwise selection was performed to identify predictors of SAH occurrence, ruptured aneurysm size, SAH outcome, and the occurrence of DIND after SAH. Data were analyzed with SPSS (release 11.5; SPSS, Chicago, IL, U.S.A.) and differences were considered significant for p values of </=0.05. Conformance with the Hardy-Weinberg equilibrium was tested by comparing the observed and expected genotype frequencies of the controls using the chi2 test.
###end p 15
###begin title 16
RESULTS
###end title 16
###begin p 17
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 426 433 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
Compared with controls, SAH cases were significantly younger with a preponderance of non-diabetics and smokers (Table 1). The SAH cases at admission had a mean GCS score of 12.9. More than 90% of patients presented with Fisher grade 3 or more, and the mean diameter of ruptured aneurysms was 6.64+/-2.74 mm. DIND after SAH occurred in 17 patients (12.8%) and more than 80% patients had a favorable outcome (GOS grade 1 or 2) (Table 2).
###end p 17
###begin p 18
###xml 175 182 175 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 624 631 624 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 792 793 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 120 127 <span type="species:ncbi:9606">patient</span>
Among the controls, the frequency of wild type homozygotes (T/T) was 88.5% and of mutant heterozygotes (T/C), 11.5%. No patient or control harbored the mutant C/C homozygote (Table 1). The frequencies of the eNOS T-786C SNP genotypes concurred with the Hardy-Weinberg equilibrium (p=0.516). No significant difference was observed between cases and controls in the distributions of the eNOS T-786C single nucleotide polymorphism (SNP) genotypes (Table 1). With regard to ruptured aneurysm size and the occurrence of DIND after SAH, no significant differences were found in the distributions of the eNOS T-786C SNP genotypes (Table 3). The mean (+/-SD) ruptured aneurysm diameter of wild-type homozygotes (T/T; 6.75+/-2.85 mm) was similar to that of mutant heterozygotes (T/C; 6.19+/-2.23 mm) (p=0.29, t-test).
###end p 18
###begin p 19
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 228 229 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Multiple logistic regression analysis after controlling for age and sex showed the eNOS T-786C SNP T/C genotype was independently associated with unfavorable outcome of SAH (GOS grade 3-5) (Exp (beta)=4.27, 95% CI 1.131-16.108, p=0.032).
###end p 19
###begin title 20
DISCUSSION
###end title 20
###begin p 21
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Much attention has been focused on the contribution made by eNOS SNPs to the development and progression of various systemic vascular diseases (23-26), because of the role played by NO in the regulations of vascular tone and hemodynamic changes. With regard to the cardiovascular system, it has been reported that high numbers of CA repeats in intron 13 and the G894T SNP in exon 7 of the eNOS gene are associated with the risk of coronary artery disease (24, 27), and that the eNOS T-786C mutation is strongly associated with a history of coronary spasm (23). Of eNOS polymorphisms that have been linked with coronary artery disease, the eNOS T-786C mutation is the only one of which functional role has been elucidated. According to the luciferase reporter gene assays performed by Nakayama et al. (23), this mutation reduces eNOS promoter activity and finally causes a reduction in NO levels. Therefore, an association between the eNOS gene variants and coronary artery disease suggests that the eNOS gene could be associated with aneurismal SAH, in which unique changes in cerebral NO levels have been reported immediately after SAH (28).
###end p 21
###begin p 22
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 342 354 <span type="species:ncbi:9606">participants</span>
Despite the potential link between the eNOS gene and aneurismal SAH, no definite evidence confirming such an association has been found. The eNOS T-786C SNP is one of the most frequently investigated mutations because it is located in the eNOS promoter region as thus potentially affects eNOS expression. In a prospective study involving 141 participants (29), it was suggested that the eNOS T-786C mutant allele does not predict susceptibility to SAH or intracranial aneurysm rupture but rather predicts susceptibility to post-SAH vasospasm. However, in the present study, the authors failed to find any relationship between eNOS T-786C SNP and the susceptibility to SAH or to DIND after SAH as did previous studies (29-31). Given the available evidence and the results of the present study, it is evident that the eNOS T-786C SNP is not a major risk factor for IA formation or SAH. However, whether the eNOS T-786C SNP contributes to vasospasm after SAH remains to be determined because the sample sizes of the vasospasm groups subjected to analysis in the studies above were too small to determine the contribution made by this SNP to vasospasm after SAH. To date, a large blood burden is the only consistently demonstrated risk factor predicting cerebral vasospasm after SAH (32).
###end p 22
###begin p 23
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
According to the stepwise multiple logistic regression analysis performed in the present study, the presence of the eNOS T-786C SNP T/C genotype should be considered as significant risk factors of outcome in cases of SAH. Interestingly, the odds ratio for an unfavorable outcome (GOS grade 3-5) after SAH for individuals with the eNOS T-786C SNP T/C genotype was 4.27 (95% CI 1.13-16.11, p=0.032). This result suggests that the eNOS -786C allele causing a reduction of NO level should be associated with an unfavorable outcome of SAH. However, the exact explanation for the unfavorable outcome of SAH in patients presenting the eNOS -786C allele is out of the scope of the present study. Nevertheless, if the result is confirmed by a larger scale study, the eNOS T-786C SNP T/C genotype could be used as a prognostic marker in individuals with SAH.
###end p 23
###begin p 24
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 572 574 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 576 578 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 971 973 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1039 1043 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1298 1299 1288 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1875 1879 1865 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 1966 1973 1956 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 2158 2160 2148 2150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 2205 2209 2195 2199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 2288 2295 2278 2285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 2359 2363 2349 2353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
###xml 1006 1014 <span type="species:ncbi:9606">patients</span>
Another controversy concerning aneurysms and the eNOS gene involves the critical size of aneurysm beyond which rupture risk increases appreciably. In the International Study of Unruptured IAs (ISUIA) (19), the rupture rate of aneurysms of >/=10 mm was approximately 20 times that of aneurysms <10 mm among patients without a prior SAH. This result suggests that aneurysm size at the time of diagnosis is an independent predictor of rupture risk. However, the fact that the vast majority of ruptured aneurysms are <10 mm in diameter at the time of diagnosis and treatment (33, 34) reinforces the notion that aneurysm size should not be used as the sole criterion for treatment decision-making. Explanations for this apparent discrepancy include the possibility that there are two distinct subpopulations of IAs; one that develops rapidly and ruptures when <10 mm in diameter and another that enlarges slowly and ruptures when >10 mm in diameter. Recently, Khurana et al. (30) suggested that among Caucasian patients with known IAs that the eNOS T-786C genotype influence aneurismal size at rupture. They found that the mean (+/-SD) ruptured aneurysm diameter for all heterozygotes (T/C; 8.5+/-5.2 mm) was significantly greater than that for the C/C (6.0+/-2.3 mm) or T/T (4.7+/-1.8 mm) homozygotes (p=0.04). If this finding is reproduced by larger scale study, genotypes could be used to predict the risk of rupture in individuals presenting with unruptured IAs. However, their suggestion is also not free of criticism due to the relatively small size studied (n=52). In addition, according to their suggestion, it should be stated that both the mutant homozygote (C/C) and the wild type homozygote (T/T) influence aneurysm development, which is difficult to rationalize. In the present study of 133 individuals with SAH, no significant differences in the distribution of the eNOS T-786C genotypes were found among the 3 groups defined on the basis of aneurysm size (Table 3). This negative finding is entirely consistent with the result of a recent larger scale multicenter study (n=527) which was performed in East-Asian population that presented with SAH (31). Considering that the distributions of the eNOS T-786C genotypes in normal controls are quite different in these populations (Table 4), discrepancies between Caucasians and East-Asians in terms of eNOS T-786C genotype distributions and their relations with aneurysm size may be attributed to ethnic differences. However, the exact explanation of the ethnic difference remains to be clear.
###end p 24
###begin p 25
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
Taken together, the eNOS T-786C mutation was not found to be associated with either a susceptibility to SAH, or with aneurysm size in Korean population. And the eNOS T-786C SNP T/C genotype could be used as a prognostic marker in individuals with SAH.
###end p 25
###begin article-title 26
Intracranial aneurysms
###end article-title 26
###begin article-title 27
Therapeutic approaches to vasospasm in subarachnoid hemorrhage
###end article-title 27
###begin article-title 28
Treatment of aneurysmal subarachnoid hemorrhage
###end article-title 28
###begin article-title 29
Attributable risk of common and rare determinants of subarachnoid hemorrhage
###end article-title 29
###begin article-title 30
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark
###end article-title 30
###begin article-title 31
Familial aneurysmal subarachnoid hemorrhage: a community based study
###end article-title 31
###begin article-title 32
Neurovascular manifestations of heritable connective tissue disorders: a review
###end article-title 32
###begin article-title 33
Genetics of intracranial aneurysms
###end article-title 33
###begin article-title 34
###xml 20 25 <span type="species:ncbi:9606">human</span>
Allele frequency of human endothelial nitric oxide synthase gene polymorphism in abdominal aortic aneurysm
###end article-title 34
###begin article-title 35
Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm
###end article-title 35
###begin article-title 36
Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11
###end article-title 36
###begin article-title 37
Nitric oxide: physiology, pathophysiology, and pharmacology
###end article-title 37
###begin article-title 38
Nitric oxide and the cerebral circulation
###end article-title 38
###begin article-title 39
###xml 51 55 <span type="species:ncbi:10116">rats</span>
Nitric oxide regulates cerebral arteriolar tone in rats
###end article-title 39
###begin article-title 40
Nitric oxide and cerebral blood flow: An update
###end article-title 40
###begin article-title 41
Pathogenesis and histology of saccular aneurysms: review of the literature
###end article-title 41
###begin article-title 42
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Spontaneous saccular cerebral aneurysm in a rat
###end article-title 42
###begin article-title 43
Natural history of unruptured intracranial aneurysms: a long-term follow-up study
###end article-title 43
###begin article-title 44
Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention
###end article-title 44
###begin article-title 45
Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by CT scanning
###end article-title 45
###begin article-title 46
###xml 51 59 <span type="species:ncbi:9606">patients</span>
The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care
###end article-title 46
###begin article-title 47
Assessment of outcome after severe brain damage
###end article-title 47
###begin article-title 48
T-786 --> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm
###end article-title 48
###begin article-title 49
High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease
###end article-title 49
###begin article-title 50
Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma
###end article-title 50
###begin article-title 51
Endothelial nitric oxide synthase Glu (298) --> Asp gene polymorphism, carotid atherosclerosis, and intima-media thickness in a general population sample
###end article-title 51
###begin article-title 52
A common variant of the endothelial nitric oxide synthase (Glu 298 --> Asp) is a major risk factor for coronary artery disease in the UK
###end article-title 52
###begin article-title 53
Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage
###end article-title 53
###begin article-title 54
Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm
###end article-title 54
###begin article-title 55
Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: a putative genetic marker differentiating small versus large ruptured intracranial aneurysms
###end article-title 55
###begin article-title 56
Influence of endothelial nitric oxide synthase T-786C single nucleotide polymorphism on aneurysm size
###end article-title 56
###begin article-title 57
Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment
###end article-title 57
###begin article-title 58
A review of size and location of ruptured intracranial aneurysms
###end article-title 58
###begin article-title 59
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professional from the Stroke Council of the American Heart Association
###end article-title 59
###begin p 60
Comparison of SAH cases with non-SAH controls
###end p 60
###begin p 61
Except for age (mean+/-SD), all results expressed as No. (% of total controls or cases).
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*One case was excluded from analysis because of failed PCR.
###end p 62
###begin p 63
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of SAH patients (n=133)
###end p 63
###begin p 64
Except for GSC score (mean+/-SD), all results expressed as No. (% of total cases). GSC score, glasgow coma scale score; SAH, subarachnoid hemorrhage; GOS, glasgow outcome scale.
###end p 64
###begin p 65
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
Distribution of clinical characteristics of cases according to eNOS T-786C SNP genotype*
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*One case was excluded from analysis because of failed PCR all results expressed as No. (% of total cases). SNP, single nucleotide polymorphism; SAH, subarachnoid hemorrhage; DIND, delayed ischemic neurological deterioration.
###end p 66
###begin p 67
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</italic>
Distribution of eNOS T-786C genotypes according to races
###end p 67
###begin p 68
Except for reference, all results expressed as % of total cases studied.
###end p 68

